S K Basu1,2,3, S Pradhan2,3, S D Barnett2,3, M Mikkelsen4, K J Kapse2, J Murnick3,4, J L Quistorff2, C A Lopez2, A J du Plessis5,3, C Limperopoulos6,7,3. 1. From the Department of Neonatology (S.K.B.). 2. Developing Brain Institute (S.K.B., S.P., S.D.B., K.J.K., J.L.Q., C.A.L., C.L.). 3. George Washington University School of Medicine (S.K.B. S.P., S.D.B., J.M., A.J.d.P., C.L.), Washington, DC. 4. Department of Radiology (M.M., J.M.), Weill Cornell Medicine, New York, New York. 5. Fetal Medicine Institute (A.J.d.P.), Children's National Hospital, Washington, DC. 6. Developing Brain Institute (S.K.B., S.P., S.D.B., K.J.K., J.L.Q., C.A.L., C.L.) climpero@childrensnational.org. 7. Division of Diagnostic Imaging and Radiology (C.L.).
Abstract
BACKGROUND AND PURPOSE: Gamma-aminobutyric acid and glutamate system disruptions may underlie neonatal brain injury. However, in vivo investigations are challenged by the need for special 1H-MR spectroscopy sequences for the reliable measurement of the neurotransmitters in this population. We used J-edited 1H-MR spectroscopy (Mescher-Garwood point-resolved spectroscopy) to quantify regional in vivo gamma-aminobutyric acid and glutamate concentrations during the early postnatal period in healthy neonates. MATERIALS AND METHODS: We prospectively enrolled healthy neonates and acquired Mescher-Garwood point-resolved spectroscopy spectra on a 3T MR imaging scanner from voxels located in the cerebellum, the right basal ganglia, and the right frontal lobe. CSF-corrected metabolite concentrations were compared for regional variations and cross-sectional temporal trends with advancing age. RESULTS: Fifty-eight neonates with acceptable spectra acquired at postmenstrual age of 39.1 (SD, 1.3) weeks were included for analysis. Gamma-aminobutyric acid (+ macromolecule) (2.56 [SD, 0.1]) i.u., glutamate (3.80 [SD, 0.2]), Cho, and mIns concentrations were highest in the cerebellum, whereas NAA (6.72 [SD, 0.2]), NAA/Cho, Cr/Cho, and Glx/Cho were highest in the basal ganglia. Frontal gamma-aminobutyric acid (1.63 [SD, 0.1]), Glx (4.33 [SD, 0.3]), Cr (3.64 [SD, 0.2]), and Cho concentrations were the lowest among the ROIs. Glx, NAA, and Cr demonstrated a significant adjusted increase with postmenstrual age (β = 0.2-0.35), whereas gamma-aminobutyric acid and Cho did not. CONCLUSIONS: We report normative regional variations and temporal trends of in vivo gamma-aminobutyric acid and glutamate concentrations reflecting the functional and maturational status of 3 distinct brain regions of the neonate. These measures will serve as important normative values to allow early detection of subtle neurometabolic alterations in high-risk neonates.
BACKGROUND AND PURPOSE: Gamma-aminobutyric acid and glutamate system disruptions may underlie neonatal brain injury. However, in vivo investigations are challenged by the need for special 1H-MR spectroscopy sequences for the reliable measurement of the neurotransmitters in this population. We used J-edited 1H-MR spectroscopy (Mescher-Garwood point-resolved spectroscopy) to quantify regional in vivo gamma-aminobutyric acid and glutamate concentrations during the early postnatal period in healthy neonates. MATERIALS AND METHODS: We prospectively enrolled healthy neonates and acquired Mescher-Garwood point-resolved spectroscopy spectra on a 3T MR imaging scanner from voxels located in the cerebellum, the right basal ganglia, and the right frontal lobe. CSF-corrected metabolite concentrations were compared for regional variations and cross-sectional temporal trends with advancing age. RESULTS: Fifty-eight neonates with acceptable spectra acquired at postmenstrual age of 39.1 (SD, 1.3) weeks were included for analysis. Gamma-aminobutyric acid (+ macromolecule) (2.56 [SD, 0.1]) i.u., glutamate (3.80 [SD, 0.2]), Cho, and mIns concentrations were highest in the cerebellum, whereas NAA (6.72 [SD, 0.2]), NAA/Cho, Cr/Cho, and Glx/Cho were highest in the basal ganglia. Frontal gamma-aminobutyric acid (1.63 [SD, 0.1]), Glx (4.33 [SD, 0.3]), Cr (3.64 [SD, 0.2]), and Cho concentrations were the lowest among the ROIs. Glx, NAA, and Cr demonstrated a significant adjusted increase with postmenstrual age (β = 0.2-0.35), whereas gamma-aminobutyric acid and Cho did not. CONCLUSIONS: We report normative regional variations and temporal trends of in vivo gamma-aminobutyric acid and glutamate concentrations reflecting the functional and maturational status of 3 distinct brain regions of the neonate. These measures will serve as important normative values to allow early detection of subtle neurometabolic alterations in high-risk neonates.
Authors: Gang Xu; Kevin G Broadbelt; Robin L Haynes; Rebecca D Folkerth; Natalia S Borenstein; Richard A Belliveau; Felicia L Trachtenberg; Joseph J Volpe; Hannah C Kinney Journal: J Neuropathol Exp Neurol Date: 2011-10 Impact factor: 3.685
Authors: Alexandra Castillo-Ruiz; Morgan Mosley; Andrew J Jacobs; Yarely C Hoffiz; Nancy G Forger Journal: Proc Natl Acad Sci U S A Date: 2018-10-15 Impact factor: 11.205
Authors: Richard A E Edden; Nicolaas A J Puts; Ashley D Harris; Peter B Barker; C John Evans Journal: J Magn Reson Imaging Date: 2013-11-13 Impact factor: 4.813
Authors: Soo Hyun Kwon; Dustin Scheinost; Cheryl Lacadie; Jennifer Benjamin; Eliza H Myers; Maolin Qiu; Karen C Schneider; Douglas L Rothman; R Todd Constable; Laura R Ment Journal: Neonatology Date: 2014-06-26 Impact factor: 4.035
Authors: Alexander Lin; Ovidiu Andronesi; Wolfgang Bogner; In-Young Choi; Eduardo Coello; Cristina Cudalbu; Christoph Juchem; Graham J Kemp; Roland Kreis; Martin Krššák; Phil Lee; Andrew A Maudsley; Martin Meyerspeer; Vladamir Mlynarik; Jamie Near; Gülin Öz; Aimie L Peek; Nicolaas A Puts; Eva-Maria Ratai; Ivan Tkáč; Paul G Mullins Journal: NMR Biomed Date: 2021-02-09 Impact factor: 4.044